BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7582903)

  • 1. Donor specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population.
    Lagoo-Deenadayalan S; Lagoo AS; Lemons JA; Lorenz HM; Bass JD; McDaniel DO; Hardy KJ; Barber WH
    Transpl Immunol; 1995 Jun; 3(2):124-34. PubMed ID: 7582903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning.
    Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H
    Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population.
    Lagoo-Deenadayalan S; Lagoo AS; Lemons JA; Lorenz HM; Bass JD; McDaniel DO; Hardy KJ; Barber WH
    Adv Nephrol Necker Hosp; 1996; 25():107-27. PubMed ID: 8717623
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance.
    Verbanac KM; Carver FM; Haisch CE; Thomas JM
    Transplantation; 1994 Mar; 57(6):893-900. PubMed ID: 8154038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease.
    Carayol G; Bourhis JH; Guillard M; Bosq J; Pailler C; Castagna L; Vernant JP; Pico JL; Hayat M; Chouaib S; Caignard A
    Transplantation; 1997 May; 63(9):1307-13. PubMed ID: 9158026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism.
    Thomas JM; Carver FM; Kasten-Jolly J; Haisch CE; Rebellato LM; Gross U; Vore SJ; Thomas FT
    Transplantation; 1994 Jan; 57(1):101-15. PubMed ID: 8291095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum.
    Oluwole SF; Engelstad K; James T
    Blood; 1993 Mar; 81(6):1658-65. PubMed ID: 8453111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory role of CD8alpha in the veto effect.
    Asiedu C; Meng Y; Wang W; Huang Z; Contreras JL; George JF; Thomas JM
    Transplantation; 1999 Feb; 67(3):372-80. PubMed ID: 10030281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow.
    Bacchetta R; Parkman R; McMahon M; Weinberg K; Bigler M; de Vries JE; Roncarolo MG
    Blood; 1995 Apr; 85(7):1944-53. PubMed ID: 7703497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine mRNA and protein expression in a mixed leukocyte reaction before and after allogeneic transfusions. Groupe Coopératif de Transplantation d'Ile de France.
    Baudouin V; Ansart-Pirenne H; Soulimani N; Lang P; Hiesse C; Sterkers G
    Transplantation; 1998 Aug; 66(3):376-84. PubMed ID: 9721808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional heterogeneity among bone marrow-derived dendritic cells conditioned by T(h)1- and T(h)2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes.
    Sato M; Iwakabe K; Ohta A; Sekimoto M; Nakui M; Koda T; Kimura S; Nishimura T
    Int Immunol; 2000 Mar; 12(3):335-42. PubMed ID: 10700468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
    Qin L; Ding Y; Tahara H; Bromberg JS
    J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenovirus-mediated CTLA4Ig and OX40Ig gene transfer induces long-term survival of cardiac allografts in rats].
    Wang GM; Sun T; Zhang YY; Yuan GH; Feng YG; Hao J; Gao X; Xie SS
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3435-9. PubMed ID: 16409867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists.
    Mencacci A; Perruccio K; Bacci A; Cenci E; Benedetti R; Martelli MF; Bistoni F; Coffman R; Velardi A; Romani L
    Blood; 2001 Mar; 97(5):1483-90. PubMed ID: 11222397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous IL-10 induces corneal transplantation immune tolerance by a mechanism associated with the altered Th1/Th2 cytokine ratio and the increased expression of TGF-β.
    Li B; Tian L; Diao Y; Li X; Zhao L; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2245-50. PubMed ID: 24676597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.